In preparing Merck's disclosures relating to access to medicines performance, we have referred to the Access to Medicine Index (ATMI)

This index is a first step toward a useful framework for transparent reporting about access to medicines performance, which will help inform our stakeholders and also enable us to compare our performance with that of peers on relevant metrics. We believe that this will help us focus on continuously improving the things that matter most. The table below summarizes where Merck disclosures can be found on the Merck website in relation to the ATMI criteria.